Basal Tumours in Bladder Cancer, Response to chemoTherapy

CompletedOBSERVATIONAL
Enrollment

293

Participants

Timeline

Start Date

February 27, 2019

Primary Completion Date

April 29, 2019

Study Completion Date

April 29, 2019

Conditions
Bladder CancerChemotherapy Effect
Interventions
COMBINATION_PRODUCT

neoadjuvant chemotherapy with cisplatine

Tumors from patient having muscle invasive bladder cancer who benefit from neoadjuvant chemotherapy with cisplatine

Trial Locations (1)

76000

DRCI, Rouen

All Listed Sponsors
collaborator

Institut Curie

OTHER

collaborator

APHP

OTHER

lead

University Hospital, Rouen

OTHER

NCT04089748 - Basal Tumours in Bladder Cancer, Response to chemoTherapy | Biotech Hunter | Biotech Hunter